how glp 1 drugs work Evolution of GLP‐1 Receptor Agonists for Diabetes Treatment Current Insights, Advantages and Challenges
Description
Accessed at pubmed.ncbi.nlm.nih.gov/28344112
Furman, B
475,480,481 The encouraging results obtained with semaglutide in patients with heart failure and a preserved ejection fraction may provide a new option for this patient population, in which additional therapy, as well as another upstream therapy for patients with a higher BMI who have indications for this condition, is urgently needed
Hepatology 51 , 15841592 (2010)
4.2 Combination therapy strategies Combining triple receptor agonists with other pharmacological agents holds promise for synergistic metabolic benefits in MASLD management
